X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-17 | AVTE | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $1.67 | +928,110 | 9,192,092 | +11% | +$1,549,944 | ||||||
| D | 2024-06-14 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -15,000 | 5,022 | -75% | -$375,450 | |||||
| D | 2024-06-14 | AVTE | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S - Sale+OE | $25.00 | -10,600 | 0 | -100% | -$265,000 | |||||
| D | 2024-06-13 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $24.50 | -6,000 | 5,602 | -52% | -$147,000 | |||||
| D | 2024-05-17 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $21.08 | -4,000 | 5,602 | -42% | -$84,332 | |||||
| D | 2024-05-16 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $21.58 | -10,000 | 0 | -100% | -$215,755 | |||||
2024-05-02 | AVTE | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S - Sale | $21.02 | -1,981 | 0 | -100% | -$41,631 | ||||||
| D | 2024-05-01 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $20.34 | -11,357 | 0 | -100% | -$230,946 | |||||
| D | 2024-04-17 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $22.37 | -6,853 | 1,291 | -84% | -$153,327 | |||||
| D | 2024-04-17 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $22.38 | -4,000 | 3,251 | -55% | -$89,522 | |||||
| D | 2024-04-16 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $24.70 | -10,000 | 0 | -100% | -$246,971 | |||||
| D | 2024-04-10 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $26.85 | -7,500 | 1,960 | -79% | -$201,392 | |||||
2024-04-09 | AVTE | Grayzel David S. | Dir | S - Sale | $28.15 | -11,882 | 1,799,232 | -1% | -$334,478 | ||||||
| D | 2024-04-01 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $30.00 | -10,000 | 0 | -100% | -$300,033 | |||||
| D | 2024-04-01 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $31.97 | -3,325 | 1,291 | -72% | -$106,317 | |||||
| D | 2024-04-01 | AVTE | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S - Sale+OE | $29.19 | -5,300 | 0 | -100% | -$154,697 | |||||
| D | 2024-04-01 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $31.23 | -12,495 | 1,960 | -86% | -$390,208 | |||||
| D | 2024-03-28 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $29.50 | -9,000 | 3,251 | -73% | -$265,500 | |||||
| D | 2024-03-27 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $27.97 | -11,068 | 1,291 | -90% | -$309,519 | |||||
| D | 2024-03-25 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $28.01 | -3,432 | 1,291 | -73% | -$96,119 | |||||
| D | 2024-03-19 | AVTE | Verwijs Marinus | CHIEF TECHNICAL OFFICER | S - Sale+OE | $26.08 | -5,300 | 0 | -100% | -$138,243 | |||||
| D | 2024-03-18 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $25.87 | -7,000 | 3,251 | -68% | -$181,057 | |||||
| D | 2024-03-18 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $25.90 | -35,057 | 1,291 | -96% | -$908,046 | |||||
| DM | 2024-03-12 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -4,067 | 1,960 | -67% | -$101,815 | |||||
| DM | 2024-03-07 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $25.03 | -25,933 | 1,960 | -93% | -$649,205 | |||||
| D | 2024-03-07 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $24.50 | -8,975 | 3,251 | -73% | -$219,888 | |||||
| D | 2024-02-23 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.50 | -511 | 3,251 | -14% | -$9,965 | |||||
| D | 2024-02-20 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $20.23 | -3,489 | 3,251 | -52% | -$70,575 | |||||
| D | 2024-02-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $17.45 | -4,600 | 1,609 | -74% | -$80,249 | |||||
| D | 2024-01-17 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.50 | -4,000 | 3,251 | -55% | -$78,000 | |||||
| D | 2024-01-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $19.16 | -4,600 | 1,609 | -74% | -$88,116 | |||||
| D | 2023-12-27 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $24.50 | -125 | 3,251 | -4% | -$3,063 | |||||
| D | 2023-12-20 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.50 | -4,000 | 3,251 | -55% | -$78,000 | |||||
| DM | 2023-12-13 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.50 | -12,000 | 3,251 | -79% | -$234,000 | |||||
| D | 2023-12-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $16.30 | -4,600 | 1,609 | -74% | -$74,996 | |||||
| D | 2023-12-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.11 | -10,283 | 1,291 | -89% | -$165,628 | |||||
| D | 2023-11-27 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.24 | -12,517 | 1,291 | -91% | -$203,237 | |||||
| DM | 2023-11-22 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $15.37 | -14,372 | 1,291 | -92% | -$220,906 | |||||
| D | 2023-11-22 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $15.00 | -13,800 | 1,609 | -90% | -$207,000 | |||||
2023-11-01 | AVTE | Verwijs Marinus | CTO | S - Sale | $10.46 | -970 | 0 | -100% | -$10,149 | ||||||
2023-11-01 | AVTE | Noyes Timothy P | CEO | S - Sale | $10.42 | -1,092 | 0 | -100% | -$11,379 | ||||||
| DM | 2023-09-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $15.06 | -3,961 | 1,291 | -75% | -$59,637 | |||||
| D | 2023-08-07 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $15.52 | -10,283 | 1,291 | -89% | -$159,580 | |||||
| D | 2023-07-28 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $18.00 | -5,478 | 0 | -100% | -$98,604 | |||||
| D | 2023-07-17 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $18.11 | -4,522 | 0 | -100% | -$81,896 | |||||
| D | 2023-07-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.66 | -10,283 | 1,291 | -89% | -$171,284 | |||||
| D | 2023-07-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $17.30 | -2,250 | 1,609 | -58% | -$38,915 | |||||
| D | 2023-06-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.28 | -10,283 | 1,291 | -89% | -$167,416 | |||||
| D | 2023-06-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $16.26 | -2,250 | 1,609 | -58% | -$36,576 | |||||
| D | 2023-05-19 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.50 | -65 | 3,251 | -2% | -$1,268 | |||||
| D | 2023-05-17 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.59 | -1,090 | 3,251 | -25% | -$21,356 | |||||
| D | 2023-05-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $20.87 | -2,250 | 1,609 | -58% | -$46,957 | |||||
| D | 2023-05-08 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $21.80 | -10,284 | 1,291 | -89% | -$224,160 | |||||
2023-05-03 | AVTE | Verwijs Marinus | SVP, CMC | S - Sale | $20.79 | -759 | 0 | -100% | -$15,779 | ||||||
| DM | 2023-05-01 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $20.63 | -15,693 | 0 | -100% | -$323,745 | |||||
| D | 2023-04-21 | AVTE | Gillies Hunter | CHIEF MEDICAL OFFICER | S - Sale+OE | $19.50 | -4,000 | 1,960 | -67% | -$78,000 | |||||
| D | 2023-04-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $18.17 | -10,283 | 0 | -100% | -$186,829 | |||||
| D | 2023-04-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $18.20 | -2,250 | 1,609 | -58% | -$40,942 | |||||
| D | 2023-04-03 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $19.39 | -15,000 | 0 | -100% | -$290,916 | |||||
| D | 2023-03-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $23.73 | -10,282 | 0 | -100% | -$243,954 | |||||
| D | 2023-03-06 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $23.75 | -2,250 | 1,609 | -58% | -$53,440 | |||||
| D | 2023-03-01 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $23.81 | -15,000 | 0 | -100% | -$357,196 | |||||
| D | 2023-02-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $24.59 | -10,284 | 0 | -100% | -$252,881 | |||||
| D | 2023-02-06 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $24.27 | -2,250 | 1,609 | -58% | -$54,612 | |||||
| D | 2023-02-01 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $22.68 | -15,000 | 0 | -100% | -$340,197 | |||||
| D | 2023-01-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $25.98 | -10,284 | 0 | -100% | -$267,203 | |||||
| D | 2023-01-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $26.40 | -2,250 | 1,609 | -58% | -$59,405 | |||||
| D | 2023-01-03 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $27.07 | -15,000 | 0 | -100% | -$406,076 | |||||
| D | 2022-12-12 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $29.43 | -2,059 | 0 | -100% | -$60,591 | |||||
| DM | 2022-12-09 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $28.43 | -13,969 | 1,960 | -88% | -$397,193 | |||||
| DM | 2022-12-08 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $22.74 | -10,394 | 0 | -100% | -$236,310 | |||||
| DM | 2022-12-07 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $21.85 | -23,648 | 1,960 | -92% | -$516,782 | |||||
| D | 2022-12-06 | AVTE | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $17.67 | -40,000 | 0 | -100% | -$706,772 | |||||
| D | 2022-12-05 | AVTE | Niven Ralph | CHIEF SCIENTIFIC OFFICER | S - Sale+OE | $17.38 | -2,250 | 1,609 | -58% | -$39,114 | |||||
| D | 2022-12-01 | AVTE | Noyes Timothy P | CEO | S - Sale+OE | $18.00 | -15,000 | 0 | -100% | -$270,000 | |||||
| D | 2022-11-30 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.06 | -85 | 1,960 | -4% | -$1,620 | |||||
| D | 2022-11-23 | AVTE | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.07 | -1,261 | 1,960 | -39% | -$24,048 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |